1 |
Schwartzkroin PA, Walsh CA : Cortical malformations and epilepsy. Ment Retard Dev Disabil Res Rev 6 : 268-280, 2000
DOI
|
2 |
Sim JC, Scerri T, Fanjul-Fernandez M, Riseley JR, Gillies G, Pope K, et al. : Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3. Ann Neurol 79 : 132-137, 2016
DOI
|
3 |
Sonenberg N, Hinnebusch AG : Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136 : 731-745, 2009
DOI
|
4 |
Southwell AL, Skotte NH, Bennett CF, Hayden MR : Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases. Trends Mol Med 18 : 634-643, 2012
DOI
|
5 |
Tang G, Gudsnuk K, Kuo SH, Cotrina ML, Rosoklija G, Sosunov A, et al. : Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 83 : 1131-1143, 2014
DOI
|
6 |
Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL : Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 8 : 1727-1734, 2005
DOI
|
7 |
Teutonico A, Schena PF, Di Paolo S : Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol 16 : 3128-3135, 2005
DOI
|
8 |
Tokuda S, Mahaffey CL, Monks B, Faulkner CR, Birnbaum MJ, Danzer SC, et al. : A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice. Hum Mol Genet 20 : 988-999, 2011
DOI
|
9 |
Abu-Remaileh M, Wyant GA, Kim C, Laqtom NN, Abbasi M, Chan SH, et al. : Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes. Science 358 : 807-813, 2017
DOI
|
10 |
Alcantara D, Timms AE, Gripp K, Baker L, Park K, Collins S, et al. : Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly. Brain 140 : 2610-2622, 2017
DOI
|
11 |
De Benedetti A, Joshi-Barve S, Rinker-Schaeffer C, Rhoads RE : Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F. Mol Cell Biol 11 : 5435-5445, 1991
DOI
|
12 |
Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P : mTOR controls mitochondrial oxidative function through a YY1-PGC-1a transcriptional complex. Nature 450 : 736-740, 2007
DOI
|
13 |
Curatolo P, Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, et al. : Adjunctive everolimus for children and adolescents with treatmentrefractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial. Lancet Child Adolesc Health 2 : 495-504, 2018
DOI
|
14 |
D'Gama AM, Geng Y, Couto JA, Martin B, Boyle EA, LaCoursiere CM, et al. : Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol 77 : 720-725, 2015
DOI
|
15 |
Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, et al. : TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 47 : 535-546, 2012
DOI
|
16 |
Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M : S6K1- and -mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314 : 467-471, 2006
DOI
|
17 |
Citraro R, Leo A, Constanti A, Russo E, De Sarro G : mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis. Pharmacol Res 107 : 333-343, 2016
DOI
|
18 |
Millichap J : Cowden syndrome with cortical malformation and epilepsy. Pediatr Neurol Briefs 34 : 7, 2013
|
19 |
Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, et al. : A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci 27 : 5546-5558, 2007
DOI
|
20 |
Mester J, Eng C : When overgrowth bumps into cancer: the PTEN-opathies. Am J Med Genet C Semin Med Genet 163C : 114-121, 2013
DOI
|
21 |
Mirzaa GM, Conway RL, Gripp KW, Lerman-Sagie T, Siegel DH, deVries LS, et al. : Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 158A : 269-291, 2012
DOI
|
22 |
Miyata H, Chiang AC, Vinters HV : Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 56 : 510-9, 2004
DOI
|
23 |
Moosa S, Bohrer-Rabel H, Altmuller J, Beleggia F, Nurnberg P, Li Y, et al. : Smith-Kingsmore syndrome: a third family with the MTOR mutation c.5395G>A p.(Glu1799Lys) and evidence for paternal gonadal mosaicism. Am J Med Genet A 173 : 264-267, 2017
DOI
|
24 |
Mroske C, Rasmussen K, Shinde DN, Huether R, Powis Z, Lu HM, et al. : Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities. BMC Med Genet 16 : 102, 2015
|
25 |
Muncy J, Butler IJ, Koenig KM : Rapamycin reduces seizure frequency in tuberous sclerosis complex. J Child Neurol 24 : 477, 2009
DOI
|
26 |
Avoli M, Bernasconi A, Mattia D, Olivier A, Hwa GG : Epileptiform discharges in the human dysplastic neocortex: in vitro physiology and pharmacology. Ann Neurol 46 : 816-826, 1999
DOI
|
27 |
Uhlmann EJ, Wong M, Baldwin RL, Bajenaru ML, Onda H, Kwiatkowski DJ, et al. : Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol 52 : 285-296, 2002
DOI
|
28 |
Nellist M, Schot R, Hoogeveen-Westerveld M, Neuteboom RF, van der Louw EJ, Lequin MH, et al. : Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia. Mol Genet Metab 114 : 467-473, 2015
DOI
|
29 |
Alfaiz AA, Micale L, Mandriani B, Augello B, Pellico MT, Chrast J, et al. : TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease. Hum Mutat 35 : 447-451, 2014
DOI
|
30 |
Aronica E, Becker AJ, Spreafico R : Malformations of cortical development. Brain Pathol 22 : 380-401, 2012
DOI
|
31 |
Backman SA, Stambolic V, Suzuki A, Haight J, Elia A, Pretorius J, et al. : Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29 : 396-403, 2001
DOI
|
32 |
Baek ST, Copeland B, Yun EJ, Kwon SK, Guemez-Gamboa A, Schaffer AE, et al. : An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development. Nat Med 21 : 1445-1454, 2015
DOI
|
33 |
Banko JL, Poulin F, Hou L, DeMaria CT, Sonenberg N, Klann E : The translation repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the hippocampus. J Neurosci 25 : 9581-9590, 2005
DOI
|
34 |
Baple EL, Maroofian R, Chioza BA, Izadi M, Cross HE, Al-Turki S, et al. : Mutations in KPTN cause macrocephaly, neurodevelopmental delay, and seizures. Am J Hum Genet 94 : 87-94, 2014
DOI
|
35 |
von der Brelie C, Waltereit R, Zhang L, Beck H, Kirschstein T : Impaired synaptic plasticity in a rat model of tuberous sclerosis. Eur J Neurosci 23 : 686-692, 2006
DOI
|
36 |
van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, et al. : Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277 : 805-808, 1997
DOI
|
37 |
Venkatesan C, Angle B, Millichap JJ : Early-life epileptic encephalopathy secondary to SZT2 pathogenic recessive variants. Epileptic Disord 18 : 195-200, 2016
DOI
|
38 |
Vezina C, Kudelski A, Sehgal SN : Rapamycin (AY-22,989), a new antifungal antibiotic I. Taxonomy of the producing Streptomycete and isolation of the active principle. J Antibiot (Tokyo) 28 : 721-726, 1975
DOI
|
39 |
Wahl SE, McLane LE, Bercury KK, Macklin WB, Wood TL : Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination. J Neurosci 34 : 4453-4465, 2014
DOI
|
40 |
Bar-Peled L, Schweitzer LD, Zoncu R, Sabatini DM : Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 150 : 1196-1208, 2012
DOI
|
41 |
Basel-Vanagaite L, Hershkovitz T, Heyman E, Raspall-Chaure M, Kakar N, Smirin-Yosef P, et al. : Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum. Am J Hum Genet 93 : 524-529, 2013
DOI
|
42 |
European Chromosome 16 Tuberous Sclerosis Consortium : Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75 : 1305-15, 1993
DOI
|
43 |
Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ, et al. : Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 14 : 843-848, 2008
DOI
|
44 |
Eisen T, Sternberg CN, Robert C, Mulders P, Pyle L, Zbinden S, et al. : Targeted therapies for renal cell carcinoma: review of adverse event management strategies. J Natl Cancer Inst 104 : 93-113, 2012
DOI
|
45 |
Eng CP, Sehgal SN, Vezina C : Activity of rapamycin (AY-22,989) against transplanted tumors. J Antibiot (Tokyo) 37 : 1231-1237, 1984
DOI
|
46 |
Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. : Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 337 : 1723-1732, 2017
|
47 |
Frankel WN, Yang Y, Mahaffey CL, Beyer BJ, O'Brien TP : Szt2, a novel gene for seizure threshold in mice. Genes Brain Behav 8 : 568-576, 2009
DOI
|
48 |
Franz DN, Agricola K, Mays M, Tudor C, Care MM, Holland-Bouley K, et al. : Everolimus for subependymal giant cell astrocytoma: 5-year final analysis. Ann Neurol 78 : 929-938, 2015
DOI
|
49 |
Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, et al. : Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol 15 : 1513-1520, 2014
DOI
|
50 |
Orloff MS, He X, Peterson C, Chen F, Chen JL, Mester JL, et al. : Germline PIK3CA and AKT1 mutations in cowden and cowden-like syndromes. Am J Hum Genet 92 : 76-80, 2013
DOI
|
51 |
Orlova KA, Parker WE, Heuer GG, Tsai V, Yoon J, Baybis M, et al. : STRADa deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest 120 : 1591-1602, 2010
DOI
|
52 |
Pajusalu S, Reimand T, Ounap K : Novel homozygous mutation in KPTN gene causing a familial intellectual disability-macrocephaly syndrome. Am J Med Genet A 167A : 1913-1915, 2015
DOI
|
53 |
Pallet N, Legendre C : Adverse events associated with mTOR inhibitors. Expert Opin Drug Saf 12 : 177-186, 2013
DOI
|
54 |
Park SM, Lim JS, Ramakrishina S, Kim SH, Kim WK, Lee J, et al. : Brain somatic mutations in MTOR disrupt neuronal ciliogenesis, leading to focal cortical dyslamination. Neuron 99 : 83-97.e7, 2018
DOI
|
55 |
Parker WE, Orlova KA, Parker WH, Birnbaum JF, Krymskaya VP, Goncharov DA, et al. : Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder. Sci Transl Med 5 : 182ra53, 2013
DOI
|
56 |
Wolfson RL, Chantranupong L, Wyant GA, Gu X, Orozco JM, Shen K, et al. : KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature 543 : 438-442, 2017
DOI
|
57 |
Way SW, Mckenna J 3rd, Mietzsch U, Reith RM, Wu HC, Gambello MJ : Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet 18 : 1252-1265, 2009
DOI
|
58 |
Weston MC, Chen H, Swann JW : Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission. J Neurosci 32 : 11441-11452, 2012
DOI
|
59 |
Wiemer-Kruel A, Woerle H, Strobl K, Bast T : Everolimus for the treatment of subependymal giant cell astrocytoma probably causing seizure aggravation in a child with tuberous sclerosis complex: a case report. Neuropediatrics 45 : 129-131, 2014
DOI
|
60 |
Dutchak PA, Laxman S, Estill SJ, Wang C, Wang Y, Wang Y, et al. : Regulation of hematopoiesis and methionine homeostasis by mTORC1 inhibitor NPRL2. Cell Rep 12 : 371-379, 2015
DOI
|
61 |
Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ, Hiatt JB, Roden WH, et al. : PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 138(Pt 6) : 1613-1628, 2015
DOI
|
62 |
Jung J, Genau HM, Behrends C : Amino acid-dependent mTORC1 regulation by the lysosomal membrane protein SLC38A9. Mol Cell Biol 35 : 2479-2494, 2015
DOI
|
63 |
Keppler-Noreuil KM, Parker VE, Darling TN, Martinez-Agosto JA : Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C Semin Med Genet 172 : 402-421, 2016
DOI
|
64 |
Klawitter J, Gottschalk S, Hainz C, Leibfritz D, Christians U, Serkova NJ : Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism. Chem Res Toxicol 23 : 608-619, 2010
DOI
|
65 |
Kowalczyk MS, Hughes JR, Babbs C, Sanchez-Pulido L, Szumska D, Sharpe JA, et al. : Nprl3 is required for normal development of the cardiovascular system. Mamm Genome 23 : 404-415, 2012
DOI
|
66 |
Krueger DA, Care MM, Agricola K, Tudor C, Mays M, Franz DN : Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma. Neurology 80 : 574-580, 2013
DOI
|
67 |
Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, et al. : Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 369 : 1801-1811, 2010
|
68 |
Krueger DA, Wilfong AA, Mays M, Talley CM, Agricola K, Tudor C, et al. : Long-term treatment of epilepsy with everolimus in tuberous sclerosis. Neurology 87 : 2408-2415, 2016
DOI
|
69 |
Pilarski R : Cowden syndrome: a critical review of the clinical literature. J Genet Couns 18 : 13-27, 2009
DOI
|
70 |
Peters JM, Taquet M, Prohl AK, Scherrer B, van Eeghen AM, Prabhu SP, et al. : Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions. Future Neurol 8 : 583-597, 2013
DOI
|
71 |
Pitkanen A, Lukasiuk K : Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 10 : 173-186, 2011
DOI
|
72 |
Oh WJ, Jacinto E : mTOR complex 2 signaling and functions. Cell Cycle 10 : 2305-2316, 2011
DOI
|
73 |
Beaumont V, Zhong N, Fletcher R, Froemke RC, Zucker RS : Phosphorylation and local presynaptic protein synthesis in calcium- and calcineurindependent induction of crayfish long-term facilitation. Neuron 32 : 489-501, 2001
DOI
|
74 |
Kuegler PB, Zimmer B, Waldmann T, Baudis B, Ilmjarv S, Hescheler J, et al. : Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX 27 : 17-42, 2010
|
75 |
Bast T, Ramantani G, Seitz A, Rating D : Focal cortical dysplasia: prevalence, clinical presentation and epilepsy in children and adults. Acta Neurol Scand 113 : 72-81, 2006
DOI
|
76 |
Baulac S : MTOR signaling pathway genes in focal epilepsies in Rossignol E, Carmant L, Lacaille JC (eds) : Progress in Brain Research. Amsterdam : Elsevier, 2016, Vol 226, pp61-79
|
77 |
Baulac S, Ishida S, Marsan E, Miquel C, Biraben A, Nguyen DK, et al. : Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol 77 : 675-683, 2015
DOI
|
78 |
Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G 2nd, et al. : mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 56 : 478-487, 2004
DOI
|
79 |
Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, et al. : SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8 : 224-236, 2008
DOI
|
80 |
Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, Lehtinen MK, et al. : Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74 : 41-48, 2012
DOI
|
81 |
Raab-Graham KF, Haddick PC, Jan YN, Jan LY : Activity- and mTORdependent suppression of Kv1.1 channel mRNA translation in dendrites. Science 314 : 144-148, 2006
DOI
|
82 |
Rabanal-Ruiz Y, Otten EG, Korolchuk VI : mTORC1 as the main gateway to autophagy. Essays Biochem 61 : 565-584, 2017
DOI
|
83 |
Blumcke I : Neuropathology of focal epilepsies: a critical review. Epilepsy Behav 15 : 34-39, 2009
DOI
|
84 |
Wyant GA, Abu-Remaileh M, Frenkel EM, Laqtom NN, Dharamdasani V, Lewis CA, et al. : Nufip1 is a ribosome receptor for starvation-induced ribophagy. Science 360 : 751-758, 2018
DOI
|
85 |
Xiong Q, Oviedo HV, Trotman LC, Zador AM : PTEN regulation of local and long-range connections in mouse auditory cortex. J Neurosci 32 : 1643-1652, 2012
DOI
|
86 |
Ben-Sahra I, Howell JJ, Asara JM, Manning BD : Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 339 : 1323-1328, 2013
DOI
|
87 |
Bercury KK, Dai J, Sachs HH, Ahrendsen JT, Wood TL, Macklin WB : Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination. J Neurosci 34 : 4466-4480, 2014
DOI
|
88 |
Bishop KM : Progress and promise of antisense oligonucleotide therapeutics for central nervous system diseases. Neuropharmacology 120 : 56-62, 2017
DOI
|
89 |
Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, Schreiber SL : Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature 377 : 441-446, 1995
DOI
|
90 |
French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, et al. : Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 388 : 2153-2163, 2016
DOI
|
91 |
Gingras A, Kennedy SG, O'Leary MA, Sonenberg N, Hay N : 4E-BP1, a repressor of mRNA translation, is phosphorylated by the Akt(PKB) signaling pathway. Genes Dev 12 : 502-513, 1998
DOI
|
92 |
Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, et al. : Regulation of 4E-BP1 phosphorylation : a novel two-step mechanism. Genes Dev 13 : 1422-1437, 1999
DOI
|
93 |
Gingras AC, Raught B, Sonenberg N : eIF4 initiation factors : effectors of mRNA recruitment of translation. Annu Rev Biochem 68 : 913-963, 1999
DOI
|
94 |
Gong X, Zhang L, Huang T, Lin T V., Miyares L, Wen J, et al. : Activating the translational repressor 4E-BP or reducing activity prevents accelerated axon growth induced by hyperactive mTOR in vivo. Hum Mol Genet 24 : 5746-5758, 2015
DOI
|
95 |
Riviere JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL, et al. : De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 44 : 934-940, 2012
DOI
|
96 |
Rennebeck G, Kleymenova EV, Anderson R, Yeung RS, Artzt K, Walker CL : Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci U S A 95 : 15629-15634, 1998
DOI
|
97 |
Ribierre T, Deleuze C, Bacq A, Baldassari S, Marsan E, Chipaux M, et al. : Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy. J Clin Investig 128 : 2452-2458, 2018
DOI
|
98 |
Ricos MG, Hodgson BL, Pippucci T, Saidin A, Ong YS, Heron SE, et al. : Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy. Ann Neurol 79 : 120-131, 2016
DOI
|
99 |
Roy A, Skibo J, Kalume F, Ni J, Rankin S, Lu Y, et al. : Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy. Elife 4 : e12703, 2015
DOI
|
100 |
Xu Q, Uliel-Sibony S, Dunham C, Sarnat H, Flores-Sarnat L, Brunga L, et al. : mTOR inhibitors as a new therapeutic strategy in treatment resistant epilepsy in hemimegalencephaly: a case report. J Child Neurol 34 : 132-138, 2019
DOI
|
101 |
Yeung RS, Katsetos CD, Klein-szanto A : Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 151 : 1477-1486, 1997
|
102 |
Yeung RS, Xiao GH, Jin F, Lee WC, Testa JR, Knudson AG : Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci U S A 91 : 11413-11416, 1994
DOI
|
103 |
Yoon BC, Zivraj KH, Holt CE : Local translation and mRNA trafficking in axon pathfinding. Results Probl Cell Differ 48 : 269-288, 2009
DOI
|
104 |
Zeng LH, Rensing NR, Zhang B, Gutmann DH, Gambello MJ, Wong M : Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum Mol Genet 20 : 445-454, 2011
DOI
|
105 |
Zeng LH, Xu L, Gutmann DH, Wong M : Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63 : 444-453, 2008
DOI
|
106 |
Zoncu R, Efeyan A, Sabatini DM : MTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12 : 21-35, 2011
DOI
|
107 |
Han JM, Jeong SJ, Park MC, Kim G, Kwon NH, Kim HK, et al. : LeucyltRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149 : 410-424, 2012
DOI
|
108 |
Gordo G, Tenorio J, Arias P, Santos-Simarro F, Garcia-Minaur S, Moreno JC, et al. : mTOR mutations in Smith-Kingsmore syndrome: four additional patients and a review. Clin Genet 93 : 762-775, 2018
DOI
|
109 |
Gu X, Orozco JM, Saxton RA, Condon KJ, Liu GY, Krawczyk PA, et al. : SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science 358 : 813-818, 2017
DOI
|
110 |
Hadamitzky M, Herring A, Kirchhof J, Bendix I, Haight MJ, Keyvani K, et al. : Repeated systemic treatment with rapamycin affects behavior and amygdala protein expression in rats. Int J Neuropsychopharmacol 21 : 592-602, 2018
DOI
|
111 |
Kumar V, Zhang MX, Swank MW, Kunz J, Wu G : Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 25 : 11288-11299, 2005
DOI
|
112 |
Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, et al. : Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29 : 404-411, 2001
DOI
|
113 |
Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, Heiberg A, et al. : De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 44 : 941-945, 2012
DOI
|
114 |
Lee SK, Kim DW : Focal cortical dysplasia and epilepsy surgery. J Epilepsy Res 3 : 43-47, 2013
DOI
|
115 |
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, et al. : mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329 : 959-964, 2010
DOI
|
116 |
Lipton JO, Sahin M : The neurology of mTOR. Neuron 84 : 275-291, 2014
DOI
|
117 |
Lim JS, Gopalappa R, Kim SH, Ramakrishna S, Lee M, Kim WI, et al. : Somatic mutations in TSC1 and TSC2 cause focal cortical dysplasia. Am J Hum Genet 100 : 454-472, 2017
DOI
|
118 |
Lim JS, Kim WI, Kang HC, Kim SH, Park AH, Park EK, et al. : Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 21 : 395-400, 2015
DOI
|
119 |
Lin TV, Hsieh L, Kimura T, Malone TJ, Bordey A : Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration. Proc Natl Acad Sci U S A 113 : 11330-11335, 2016
DOI
|
120 |
Ljungberg MC, Bhattacharjee MB, Lu Y, Armstrong DL, Yoshor D, Swann JW, et al. : Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol 60 : 420-429, 2006
DOI
|
121 |
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM : Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 : 1098-1101, 2005
DOI
|
122 |
Sabatini DM : Twenty-five years of mTOR: uncovering the link from nutrients to growth. Proc Natl Acad Sci U S A 114 : 11818-11825, 2017
DOI
|
123 |
Capo-Chichi JM, Tcherkezian J, Hamdan FF, Decarie JC, Dobrzeniecka S, Patry L, et al. : Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly. J Med Genet 50 : 740-744, 2013
DOI
|
124 |
Cardamone M, Flanagan D, Mowat D, Kennedy SE, Chopra M, Lawson JA : Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex. J Pediatr 164 : 1195-1200, 2014
DOI
|
125 |
Carvill GL, Crompton DE, Regan BM, McMahon JM, Saykally J, Zemel M, et al. : Epileptic spasms are a feature of DEPDC5 mTORopathy. Neurol Genet 1 : e17, 2015
DOI
|
126 |
Hentges K, Thompson K, Peterson A : The flat-top gene is required for the expansion and regionalization of the telencephalic primordium. Development 126 : 1601-9, 1999
DOI
|
127 |
Hiremath LS, Webb NR, Rhoads RE : Immunological detection of the messenger RNA cap-binding protein. J Biol Chem 260 : 7843-7849, 1985
DOI
|
128 |
Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH : RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78 : 35-43, 1994
DOI
|
129 |
Salinas V, Vega P, Piccirilli MV, Chicco C, Ciraolo C, Christiansen S, et al. : Identification of a somatic mutation in the RHEB gene through high depth and ultra-high depth next generation sequencing in a patient with Hemimegalencephaly and drug resistant Epilepsy. Eur J Med Genet, 2018 [Epub ahead of print]
|
130 |
Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, et al. : The rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320 : 1496-1501, 2008
DOI
|
131 |
Sare RM, Song A, Loutaev I, Cook A, Maita I, Lemons A, et al. : Negative effects of chronic rapamycin treatment on behavior in a mouse model of fragile X syndrome. Front Mol Neurosci 10 : 452, 2018
DOI
|
132 |
Saxton RA, Sabatini DM : mTOR signaling in growth, metabolism, and disease. Cell 168 : 960-976, 2017
DOI
|
133 |
Scerri T, Riseley JR, Gillies G, Pope K, Burgess R, Mandelstam SA, et al. : Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5. Ann Clin Transl Neurol 2 : 575-580, 2015
DOI
|
134 |
Schick V, Majores M, Engels G, Spitoni S, Koch A, Elger CE, et al. : Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias. Acta Neuropathol 112 : 715-725, 2006
DOI
|
135 |
Chen HH, Chen C, Hung SC, Liang SY, Lin SC, Hsu TR, et al. : Cognitive and epilepsy outcomes after epilepsy surgery caused by focal cortical dysplasia in children: early intervention maybe better. Child's Nerv Syst 30 : 1885-1895, 2014
DOI
|
136 |
Casadio A, Martin KC, Giustetto M, Zhu H, Chen M, Bartsch D, et al. : A transient, neuron-wide form of creb-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell 99 : 221-237, 1999
DOI
|
137 |
Cen Z, Guo Y, Lou Y, Jiang B, Wang J, Feng J : De novo mutation in DEPDC5 associated with unilateral pachygyria and intractable epilepsy. Seizure 50 : 1-3, 2017
DOI
|
138 |
Cepeda C, Levinson S, Yazon VW, Barry J, Mathern GW, Fallah A, et al. : Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non-mTOR-mediated etiologies. Epilepsia Open 3(Suppl Suppl 2) : 180-190, 2018
|
139 |
Cheung KM, Lam CW, Chan YK, Siu WK, Yong L : Atypical focal cortical dysplasia in a patient with Cowden syndrome. Hong Kong Med J 20 : 165-167, 2014
|
140 |
Child ND, Cascino GD : Mystery case: Cowden syndrome presenting with partial epilepsy related to focal cortical dysplasia. Neurology 81 : e98-e99, 2013
DOI
|
141 |
Huber KM, Kayser MS, Bear MF : Role for rapid dendritic protein synthesis in hippocampal depression. Science 288 : 1254-1257, 2000
DOI
|
142 |
Holz MK, Ballif BA, Gygi SP, Blenis J : mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123 : 569-580, 2005
DOI
|
143 |
Hou L, Klann E : Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 24 : 6352-6361, 2004
DOI
|
144 |
Hsieh LS, Wen JH, Claycomb K, Huang Y, Harrsch FA, Naegele JR, et al. : Convulsive seizures from experimental focal cortical dysplasia occur in dependently of cell misplacement. Nat Commun 7 : 11753, 2016
DOI
|
145 |
Hughes J, Dawson R, Tea M, McAninch D, Piltz S, Jackson D, et al. : Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling. Sci Rep 7 : 12618, 2017
DOI
|
146 |
Iffland PH 2nd, Crino PB : Focal cortical dysplasia: gene mutations, cell signaling, and therapeutic implications. Annu Rev Pathol 12 : 547-571, 2017
DOI
|
147 |
Inoki K, Li Y, Xu T, Guan KL : Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17 : 1829-1834, 2003
DOI
|
148 |
Heitman J, Movva NR, Hall MN : Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253 : 905-909, 1991
DOI
|
149 |
Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, D'Arcangelo G : Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech 2 : 389-398, 2009
DOI
|
150 |
Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J : Rheb binds and regulates the mTOR kinase. Curr Biol 15 : 702-713, 2005
DOI
|
151 |
Luikart BW, Schnell E, Washburn EK, Bensen AL, Tovar KR, Westbrook GL : Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J Neurosci 31 : 4345-4354, 2011
DOI
|
152 |
Marchese M, Conti V, Valvo G, Moro F, Muratori F, Tancredi R, et al. : Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening. BMC Med Genet 15 : 26, 2014
DOI
|
153 |
Marsan E, Baulac S : Review: mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy. Neuropathol Appl Neurobiol 44 : 6-17, 2018
DOI
|
154 |
Marsan E, Ishida S, Schramm A, Weckhuysen S, Muraca G, Lecas S, et al. : Depdc5 knockout rat: a novel model of mTORopathy. Neurobiol Dis 89 : 180-189, 2016
DOI
|
155 |
Martel RR, Klicius J, Galet S : Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol 55 : 48-51, 1977
DOI
|
156 |
Martinez-Lizana E, Fauser S, Brandt A, Schuler E, Wiegand G, Doostkam S, et al. : Long-term seizure outcome in pediatric patients with focal cortical dysplasia undergoing tailored and standard surgical resections. Seizure 62 : 66-73, 2018
DOI
|
157 |
Mc Cormack A, Sharpe C, Gregersen N, Smith W, Hayes I, George AM, et al. : 12q14 microdeletions: additional case series with confirmation of a macrocephaly region. Case Rep Genet 2015 : 192071, 2015
|
158 |
Crino PB : The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol 12 : 379-392, 2016
DOI
|
159 |
Crino PB : Focal brain malformations: a spectrum of disorders along the mTOR cascade. Novartis Found Smyp 288 : 260-272; discussion 272-281, 2007
|